Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:470 (1 March), doi:10.1136/bmj.39503.345694.DB
Fred Charatan
1 Florida
| The first 150 words of the full text of this article appear below. |
In a landmark decision, the US Supreme Court voted by eight to one last month to bar a lawsuit in a state court brought by the widow of a man injured by a cardiac catheter that had been approved for sale by the Food and Drug Administration.
When Congress enacted the Medical Device Amendments of 1976 to the Federal Food, Drug, and Cosmetic Act, it gave the responsibility for overseeing the safety of medical devices to the FDA and over-ruled state oversight laws.
The dispute the Supreme Court had to settle was whether an injured patient could challenge the FDAs decision by suing in a state court for products that have received federal approval.
Charles Riegel survived open heart surgery but died in 2004 after a catheter ruptured in his coronary artery. His widow, Donna Riegel, brought a suit against device manufacturer Medtronic. The catheter had received premarket approval from
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?